KRAS and lung carcinoma: Using this approach, a panel of murine lung cancer cell lines has been developed that expresses the major drivers of human LUAD: KRAS (both G12D and G12C mutants), EGFR mutations, EML4-ALK fusions, and RET fusions (see Table 1).